United States ex rel. Streck v. Eli Lilly
On May 18, 2026, the Supreme Court declined to grant review in a case challenging the constitutionality of the False Claims Act’s qui tam provisions. The denial was a setback for WLF, whose brief contended that these provisions unconstitutionally allow private relators to exercise the President’s executive authority without any meaningful oversight in violation of Article II.